A detailed history of Fmr LLC transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Fmr LLC holds 6,436,123 shares of AVIR stock, worth $21.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,436,123
Previous 5,779,029 11.37%
Holding current value
$21.2 Million
Previous $23.3 Million 8.75%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$3.31 - $4.04 $2.17 Million - $2.65 Million
657,094 Added 11.37%
6,436,123 $21.3 Million
Q1 2024

May 13, 2024

BUY
$3.09 - $4.56 $1.32 Million - $1.95 Million
428,370 Added 8.01%
5,779,029 $23.3 Million
Q4 2023

Feb 13, 2024

SELL
$2.8 - $3.35 $3.09 Million - $3.69 Million
-1,101,891 Reduced 17.08%
5,350,659 $16.3 Million
Q3 2023

Nov 13, 2023

SELL
$3.0 - $3.79 $6.13 Million - $7.75 Million
-2,044,756 Reduced 24.06%
6,452,550 $19.4 Million
Q2 2023

Aug 11, 2023

SELL
$3.21 - $5.06 $9.87 Million - $15.6 Million
-3,076,073 Reduced 26.58%
8,497,306 $31.8 Million
Q1 2023

May 11, 2023

SELL
$3.0 - $4.97 $492,090 - $815,229
-164,030 Reduced 1.4%
11,573,379 $38.8 Million
Q4 2022

Feb 13, 2023

SELL
$4.35 - $6.17 $3.27 Million - $4.64 Million
-751,337 Reduced 6.02%
11,737,409 $56.5 Million
Q3 2022

Nov 10, 2022

SELL
$5.49 - $8.79 $278,502 - $445,907
-50,729 Reduced 0.4%
12,488,746 $71.1 Million
Q2 2022

Aug 12, 2022

SELL
$5.33 - $8.18 $214,884 - $329,784
-40,316 Reduced 0.32%
12,539,475 $89 Million
Q1 2022

May 13, 2022

BUY
$5.5 - $9.19 $629,101 - $1.05 Million
114,382 Added 0.92%
12,579,791 $90.8 Million
Q4 2021

Feb 14, 2022

BUY
$7.67 - $44.59 $374,878 - $2.18 Million
48,876 Added 0.39%
12,465,409 $111 Million
Q3 2021

Nov 15, 2021

BUY
$21.33 - $35.06 $128,043 - $210,465
6,003 Added 0.05%
12,416,533 $435 Million
Q2 2021

Aug 13, 2021

BUY
$19.22 - $59.08 $239 Million - $733 Million
12,410,530 New
12,410,530 $267 Million

Others Institutions Holding AVIR

About Atea Pharmaceuticals, Inc.


  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $274M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.